Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 1
1967 3
1968 1
1970 1
1971 1
1972 3
1973 2
1974 2
1975 2
1976 2
1977 3
1978 4
1979 1
1980 5
1981 2
1982 3
1983 4
1984 4
1985 1
1986 4
1987 14
1988 16
1989 9
1990 12
1991 19
1992 30
1993 18
1994 23
1995 20
1996 17
1997 26
1998 22
1999 27
2000 35
2001 33
2002 41
2003 46
2004 62
2005 50
2006 58
2007 45
2008 61
2009 48
2010 51
2011 56
2012 75
2013 86
2014 70
2015 90
2016 83
2017 73
2018 69
2019 50
2020 60
2021 76
2022 77
2023 45
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

1,602 results

Results by year

Filters applied: . Clear all
Page 1
Tuberous Sclerosis Complex: A Review.
Randle SC. Randle SC. Pediatr Ann. 2017 Apr 1;46(4):e166-e171. doi: 10.3928/19382359-20170320-01. Pediatr Ann. 2017. PMID: 28414398 Review.
Tuberous sclerosis complex (TSC) is a neurocutaneous syndrome that can present at any age and can affect multiple organ systems. ...Specific guidelines for diagnosis, surveillance, and management have been proposed by the International Tuberous Scle …
Tuberous sclerosis complex (TSC) is a neurocutaneous syndrome that can present at any age and can affect multiple organ …
Tuberous sclerosis complex: review based on new diagnostic criteria.
Portocarrero LKL, Quental KN, Samorano LP, Oliveira ZNP, Rivitti-Machado MCDM. Portocarrero LKL, et al. An Bras Dermatol. 2018 Jun;93(3):323-331. doi: 10.1590/abd1806-4841.20186972. An Bras Dermatol. 2018. PMID: 29924239 Free PMC article. Review.
Tuberous sclerosis complex is a multisystemic, autosomal dominant genetic disorder with complete penetrance, that can evolve with hamartomas in multiple organs, such as skin, central nervous system, kidney and lung. ...The diagnostic criteria for tuberous …
Tuberous sclerosis complex is a multisystemic, autosomal dominant genetic disorder with complete penetrance, that can evolve w …
Tuberous Sclerosis Complex.
Islam MP. Islam MP. Semin Pediatr Neurol. 2021 Apr;37:100875. doi: 10.1016/j.spen.2021.100875. Epub 2021 Feb 11. Semin Pediatr Neurol. 2021. PMID: 33892851 Review.
Affecting approximately 1 per 6000-10,000 individuals, tuberous sclerosis complex (TSC) is a neurocutaneous disorder that is not only uncommon but at risk to go underrecognized. ...Among medical subspecialists, the pediatric neurologist is often responsible for maki …
Affecting approximately 1 per 6000-10,000 individuals, tuberous sclerosis complex (TSC) is a neurocutaneous disorder that is n …
Tuberous sclerosis: a review of the past, present, and future.
Uysal SP, Şahin M. Uysal SP, et al. Turk J Med Sci. 2020 Nov 3;50(SI-2):1665-1676. doi: 10.3906/sag-2002-133. Turk J Med Sci. 2020. PMID: 32222129 Free PMC article. Review.
Tuberous sclerosis complex (TSC) is an autosomal dominant, multisystem disorder that is characterized by cellular and tissue dysplasia in several organs. ...In 2012, the diagnostic criteria for TSC were revised by the International Tuberous Sclerosis C …
Tuberous sclerosis complex (TSC) is an autosomal dominant, multisystem disorder that is characterized by cellular and tissue d …
Tuberous sclerosis.
Curatolo P, Bombardieri R, Jozwiak S. Curatolo P, et al. Lancet. 2008 Aug 23;372(9639):657-68. doi: 10.1016/S0140-6736(08)61279-9. Lancet. 2008. PMID: 18722871 Review.
Variations in the distribution, number, size, and location of lesions cause the clinical syndrome to vary, even between relatives. Most features of tuberous sclerosis become evident only in childhood after 3 years of age, limiting their usefulness for early d …
Variations in the distribution, number, size, and location of lesions cause the clinical syndrome to vary, even between relatives. Mo …
Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy.
Aronica E, Specchio N, Luinenburg MJ, Curatolo P. Aronica E, et al. Brain. 2023 Jul 3;146(7):2694-2710. doi: 10.1093/brain/awad048. Brain. 2023. PMID: 36806388 Free PMC article. Review.
Epileptogenesis in infants with tuberous sclerosis complex (TSC) is a gradual and dynamic process, leading to early onset and difficult-to-treat seizures. ...Pre-symptomatic administration of vigabatrin, a GABAergic drug, delays seizure onset and reduces the risk of …
Epileptogenesis in infants with tuberous sclerosis complex (TSC) is a gradual and dynamic process, leading to early onset and …
Tuberous sclerosis complex.
Henske EP, Jóźwiak S, Kingswood JC, Sampson JR, Thiele EA. Henske EP, et al. Nat Rev Dis Primers. 2016 May 26;2:16035. doi: 10.1038/nrdp.2016.35. Nat Rev Dis Primers. 2016. PMID: 27226234 Review.
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder that affects multiple organ systems and is caused by loss-of-function mutations in one of two genes: TSC1 or TSC2. ...
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder that affects multiple organ systems and is caused by loss-o …
Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy.
Curatolo P, Specchio N, Aronica E. Curatolo P, et al. Lancet Neurol. 2022 Sep;21(9):843-856. doi: 10.1016/S1474-4422(22)00213-7. Lancet Neurol. 2022. PMID: 35963265 Review.
Tuberous sclerosis complex is a rare genetic disease associated with mutations in the TSC1 or TSC2 genes, which cause overactivation of the mTOR complex. ...Vigabatrin has been used successfully as a treatment in infants with tuberous sclerosis complex …
Tuberous sclerosis complex is a rare genetic disease associated with mutations in the TSC1 or TSC2 genes, which cause overacti …
Current and future pharmacotherapy options for drug-resistant epilepsy.
Elkommos S, Mula M. Elkommos S, et al. Expert Opin Pharmacother. 2022 Dec;23(18):2023-2034. doi: 10.1080/14656566.2022.2128670. Epub 2022 Sep 27. Expert Opin Pharmacother. 2022. PMID: 36154780 Review.
EXPERT OPINION: Current pharmacotherapy options for drug-resistant epilepsy include perampanel, brivaracetam and the newly approved cenobamate for focal epilepsies; cannabidiol (Epidiolex) for Lennox-Gastaut Syndrome (LGS), Dravet and Tuberous Sclerosis Compl …
EXPERT OPINION: Current pharmacotherapy options for drug-resistant epilepsy include perampanel, brivaracetam and the newly approved cenobama …
Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.
Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Northrup H, et al. Pediatr Neurol. 2013 Oct;49(4):243-54. doi: 10.1016/j.pediatrneurol.2013.08.001. Pediatr Neurol. 2013. PMID: 24053982 Free PMC article.
BACKGROUND: Tuberous sclerosis complex is highly variable in clinical presentation and findings. ...METHODS: The 2012 International Tuberous Sclerosis Complex Consensus Group, comprising 79 specialists from 14 countries, was organized into 12 subcommit …
BACKGROUND: Tuberous sclerosis complex is highly variable in clinical presentation and findings. ...METHODS: The 2012 Internat …
1,602 results